Hurtsellers Christine
Transaction: 05/06/2026
BUY
Change
+472
Price
$13.14
Filing
05/07/2026
Type
BUY
John Hancock Premium Dividend Fund
PDT • Asset Management
$11.82
▲ +0.01 (+0.08%)
Current price
EarningsLatest report: Oct 31, 2025
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$582.24M
Growth
3.6%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 76.4%Positive revenue growth · 13.7%Consistent free cash flow · 4/5Reasonable earnings multiple · 9.38Manageable debt level · 0.54
Financial data as of: Oct 31, 2025, 12:00 AM UTCLast earnings update: Dec 24, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$11.82
Change0.08%
Shares Out49.26M
Market Cap$582.24M
Enterprise Value$955.94M
52W Range12.53 - 13.65
Beta0.69
P/E2.20
P/S3.96
P/B0.85
P/FCF5.91
EV/Sales6.51
Price$11.82
Change0.08%
Shares Out49.26M
Market Cap$582.24M
Enterprise Value$955.94M
52W Range12.53 - 13.65
Beta0.69
P/E2.20
P/S3.96
P/B0.85
P/FCF5.91
EV/Sales6.51
EV/EBITDA13.96
EV/FCF9.70
Earnings Yield45.52%
FCF Yield16.93%
Dividend Yield16.75%
Gross Margin78.69%
Oper. Margin76.44%
Profit Margin76.44%
Debt/Eq0.54
Current Ratio3.99
Quick Ratio3.99
Revenue 5Y3.61%
FCF 5Y-100.00%
Volume129.44K
Avg Volume126.50K
Investment DNA
How strong this company looks for long-term investors
70
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
78/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
74/100
Why this score▼
Stable or improving margins · 76.4%Positive revenue growth · 13.7%Consistent free cash flow · 4/5Reasonable earnings multiple · 9.38Manageable debt level · 0.54Healthy liquidity · 3.99
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Phelan Kenneth J
Transaction: 01/26/2026
BUY
Change
—
Price
$12.92
Filing
01/27/2026
Type
BUY
Phelan Kenneth J
Transaction: 11/12/2025
OTHER
Change
0
Price
Not reported
Filing
11/17/2025
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hurtsellers Christine | BUY | +472 | $13.14 | 05/06/2026 | 05/07/2026 |
| Phelan Kenneth J | BUY | — | $12.92 | 01/26/2026 | 01/27/2026 |
| Phelan Kenneth J | OTHER | 0 | Not reported | 11/12/2025 | 11/17/2025 |
| Hurtsellers Christine | OTHER | 0 | Not reported | 11/12/2025 | 11/17/2025 |
| Georgountzos Effie | OTHER | 0 | Not reported | 06/16/2025 | 07/31/2025 |
| Wright Thomas Rowe | BUY | +929 | $11.85 | 04/08/2025 | 04/09/2025 |
| Bacic William K | BUY | +800 | $12.55 | 01/14/2025 | 01/15/2025 |
| Ellison Noni L | BUY | +890 | $12.64 | 12/23/2024 | 12/26/2024 |
| Nataupsky Jeff | OTHER | 0 | Not reported | 10/31/2024 | 11/06/2024 |
| Carrington Patricia | OTHER | 0 | Not reported | 09/26/2024 | 10/02/2024 |
| Bacic William K | OTHER | 0 | Not reported | 08/01/2024 | 08/08/2024 |
| Wright Thomas Rowe | OTHER | 0 | Not reported | 08/01/2024 | 08/08/2024 |
| Silva Fernando A | OTHER | 0 | Not reported | 07/01/2024 | 07/02/2024 |
| McCubbin Terence A | OTHER | 0 | Not reported | 05/13/2024 | 05/15/2024 |
| Garfield Dean | BUY | — | $12.03 | 01/02/2024 | 01/04/2024 |
| Ellison Noni L | BUY | +1,185 | $9.35 | 10/12/2023 | 10/16/2023 |
| McFetridge Andy | OTHER | 0 | Not reported | 10/06/2023 | 10/10/2023 |
| Feinberg Kristie | OTHER | 0 | Not reported | 05/16/2023 | 05/23/2023 |
| Lo York | OTHER | 0 | Not reported | 12/15/2022 | 12/23/2022 |
| PRUCHANSKY STEVEN R | SELL | -2,611 | $15.66 | 08/05/2022 | 08/09/2022 |